Is it possible that this could be helpful to those whose immune systems have been battered by a vaccine(s)? copied from link................. https://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf "Bernard…
Is it possible that this could be helpful to those whose immune systems have been battered by a vaccine(s)? copied from link................. https://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf "Bernard Bihari, MD: Low-dose Naltrexone for
Normalizing Immune System Function
CONVERSATIONS
Bernard Bihari, MD, (1931-2010) was the discoverer of the
clinical effects of low-dose naltrexone (LDN) in humans. In his
groundbreaking clinical trial of patients with HIV/AIDS at
Downstate Medical Center in 1985-86, Dr Bihari discovered
the significant effectiveness of low-dose naltrexone in protecting the battered immune systems of those who were infected.
With that knowledge, he entered private practice in an attempt
to counter the then untreatable disease. As Dr Bihari explains
below, the immune-system normalizing effect of the drug
application he discovered applies to a wide range of autoimmune disorders.
This interview was provided by Dr Bihari’s widow, from a
videotape discovered after his death. The interview was transcribed and curated by Julia Schopick, author of Honest
Medicine (http://www.honestmedicine.com) and champion of
effective, cost-efficient treatments that are neglected by current
practice. (Altern Ther Health Med. 2013;19(2):56-65.)"